Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Eight-year follow-up study of brain atrophy in patients with MS.

Fisher E, Rudick RA, Simon JH, Cutter G, Baier M, Lee JC, Miller D, Weinstock-Guttman B, Mass MK, Dougherty DS, Simonian NA.

Neurology. 2002 Nov 12;59(9):1412-20.

PMID:
12427893
2.

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.

Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Kooijmans MF, Sandrock AW, Rudick RA, Simon JH, Simonian NA, Tsao EC, Whitaker JN; IMPACT Investigators.

Neurology. 2002 Sep 10;59(5):679-87.

PMID:
12221157
3.

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.

Rudick RA, Goodkin DE, Jacobs LD, Cookfair DL, Herndon RM, Richert JR, Salazar AM, Fischer JS, Granger CV, Simon JH, Alam JJ, Simonian NA, Campion MK, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munschauer FE, Priore RL, Pullicino PM, Scherokman BJ, Weistock-Guttman B, Whitham RH; Multiple Sclerosis Collaborative Research Group.

Neurology. 2001 Dec;57(12 Suppl 5):S25-30. No abstract available.

PMID:
11902591
4.

Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.

Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Jak AJ, Kniker JE, Kooijmans MF, Lull JM, Sandrock AW, Simon JH, Simonian NA, Whitaker JN.

Arch Neurol. 2001 Jun;58(6):961-7.

PMID:
11405811
5.

Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS.

Rudick RA, Cutter G, Baier M, Fisher E, Dougherty D, Weinstock-Guttman B, Mass MK, Miller D, Simonian NA.

Neurology. 2001 May 22;56(10):1324-30.

PMID:
11376182
6.

Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients.

Fisher E, Rudick RA, Cutter G, Baier M, Miller D, Weinstock-Guttman B, Mass MK, Dougherty DS, Simonian NA.

Mult Scler. 2000 Dec;6(6):373-7.

PMID:
11212131
7.

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW.

N Engl J Med. 2000 Sep 28;343(13):898-904.

8.

Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

Rudick RA, Cookfair DL, Simonian NA, Ransohoff RM, Richert JR, Jacobs LD, Herndon RM, Salazar AM, Fischer JS, Granger CV, Goodkin DE, Simon JH, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munchsauer FE, O'Reilly K, Priore RL, Whitham RH, et al.

J Neuroimmunol. 1999 Jan 1;93(1-2):8-14.

PMID:
10378864
9.

Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration.

Rogge MC, Simonian NA, Jones WE.

Eur J Neurol. 1999 May;6(3):375-7. No abstract available.

PMID:
10210923
10.

"Summary measure" statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis.

Simonian NA, McAllister A, Lull J.

J Neurol Neurosurg Psychiatry. 1999 Apr;66(4):553-4. No abstract available.

11.

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG)

Rudick RA, Simonian NA, Alam JA, Campion M, Scaramucci JO, Jones W, Coats ME, Goodkin DE, Weinstock-Guttman B, Herndon RM, Mass MK, Richert JR, Salazar AM, Munschauer FE 3rd, Cookfair DL, Simon JH, Jacobs LD.

Neurology. 1998 May;50(5):1266-72.

PMID:
9595973
13.

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

Rudick RA, Goodkin DE, Jacobs LD, Cookfair DL, Herndon RM, Richert JR, Salazar AM, Fischer JS, Granger CV, Simon JH, Alam JJ, Simonian NA, Campion MK, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munschauer FE, Priore RL, Whitham RH, et al.

Neurology. 1997 Aug;49(2):358-63.

PMID:
9270562
14.

Effects of nifedipine and nicardipine on regional cerebral blood flow distribution in patients with arterial hypertension.

Akopov SE, Simonian NA, Kazarian AV.

Methods Find Exp Clin Pharmacol. 1996 Dec;18(10):685-92.

PMID:
9121225
15.

Kainic acid induces apoptosis in neurons.

Simonian NA, Getz RL, Leveque JC, Konradi C, Coyle JT.

Neuroscience. 1996 Dec;75(4):1047-55.

PMID:
8938740
16.

Kainate induces apoptosis in neurons.

Simonian NA, Getz RL, Leveque JC, Konradi C, Coyle JT.

Neuroscience. 1996 Oct;74(3):675-83.

PMID:
8884764
17.
18.

Oxidative stress in neurodegenerative diseases.

Simonian NA, Coyle JT.

Annu Rev Pharmacol Toxicol. 1996;36:83-106. Review.

PMID:
8725383
19.

Functional alterations in neural circuits in Alzheimer's disease.

Simonian NA, Hyman BT.

Neurobiol Aging. 1995 May-Jun;16(3):305-9. Review.

PMID:
7566339
20.
21.

Calcium/calmodulin-dependent protein kinase II immunostaining is preserved in Alzheimer's disease hippocampal neurons.

Simonian NA, Elvhage T, Czernik AJ, Greengard P, Hyman BT.

Brain Res. 1994 Sep 19;657(1-2):294-9.

PMID:
7820630
22.
23.

Functional integrity of neural systems related to memory in Alzheimer's disease.

Simonian NA, Rebeck GW, Hyman BT.

Prog Brain Res. 1994;100:245-54. Review. No abstract available.

PMID:
7938525
24.

Ifosfamide causes a diazepam-sensitive encephalopathy.

Simonian NA, Gilliam FG, Chiappa KH.

Neurology. 1993 Dec;43(12):2700-2.

PMID:
8255482
25.

Functional alterations in Alzheimer's disease: diminution of cytochrome oxidase in the hippocampal formation.

Simonian NA, Hyman BT.

J Neuropathol Exp Neurol. 1993 Nov;52(6):580-5.

PMID:
8229076
26.

Specific infection of central nervous system white matter by a variant of gross murine leukemia virus.

Simonian NA, Rosenthal LA, Korostoff J, Hickey WF, Blank KJ, Gaulton GN.

Virology. 1990 Jul;177(1):384-7.

PMID:
2353463
27.

[The influence of an inhibitor and stimulant of nucleic acid synthesis on the development of compensatory hypertrophy and the function of a solitary kidney].

Meerson FZ, Simonian NA, Barardzhian AG, Leĭkina EM.

Dokl Akad Nauk SSSR. 1965 Dec 21;165(6):1409-12. Russian. No abstract available.

PMID:
4164591
28.

[Senile changes in organs after a prolonged hyperactivity].

Meerson FZ, Bazardzhian AG, Leĭkina EM, Simonian NA.

Dokl Akad Nauk SSSR. 1965 May 11;162(2):441-4. Russian. No abstract available.

PMID:
5884408

Supplemental Content

Loading ...
Support Center